Paul Blunden, a Director, acquired 999,427 Common Shares on a control or direction basis for registered holder Elizabeth G. Blunden at a price of $0.300 through a prospectus or prospectus exempt offering on September 21st, 2018. The insider also acquired 999,427 Warrants with an exercise price of $0.360 for 5 long years. This represents a $299,828 investment into the company's shares and an account share holdings change of greater than 100%.
CVR Medical is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.
CVR Medical Corp, formerly Big Bar Resources Corp, is a Canada-based medical technology company. The Company is engaged in the development and advancement of technology at work within the healthcare sector. The Company offers Carotid Stenotic Scan (CSS), a screening tool designed to detect and measure carotid arterial stenosis or occlusion for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). CSS is in the Clinical phase of the development process. It offers its product for patients, payers, and healthcare providers.
No Comments